Weight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS Insider
22. Juli 2024 13:29 ET
|
SNS Insider pvt ltd
Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Weight Loss Drugs Market Size & Growth Analysis: “According to SNS Insider Research, The Weight Loss Drugs Market size is valued at US$ 1.92 Billion...
Global Obesity Drugs Market valued at $2.3 billion (2022), is Projected to Witness a Significant Growth Rate of 25% by 2027
23. Januar 2023 09:30 ET
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by...
Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz
07. September 2016 08:00 ET
|
Researchmoz Global Pvt Ltd
Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...
Sticking to Your New Year's Weight Resolution
07. Januar 2015 08:08 ET
|
Obesity Medicine Association
DENVER, Jan. 7, 2015 (GLOBE NEWSWIRE) -- It's no secret that most people want to lose weight this time of year. But even if the weight comes off easily, there's still the life-long struggle to...